Language Selector

    IMI Call Open on Therapeutics and Diagnostics Combatting Coronavirus Infections

    Published on 03 March 2020
    Author: Sasha Hugentobler, National Contact Point Health

    The Innovative Medicines Initiative has now launched IMI2 - Call 21 on the development of therapeutics and diagnostics combatting coronavirus infections.

    IMI2 - Call 21 on the development of therapeutics and diagnostics combatting coronavirus infections is a single stage Call for proposals. Please note that preventive vaccines are specifically excluded from the scope of the Call.

    Deadline for short proposals: 31 March 2020
    Call web page

    All topic texts, Call documentation and details of how to apply can be found on the IMI website.

    Webinars
    IMI will hold a webinar on IMI2 - Call 21 on Wednesday 4 March at 14:30. Registration for the webinar is now closed, as the webinar is full. However, the webinar will be recorded, and the recording and slides will be published on the IMI website after the webinar. In addition, applicants who wish to be part of the webinar participant list for networking purposes should follow the instructions on the webinar page.

    The IMI website includes pages with advice for applicants and guidance on how to find project partners.